Charles Anthony Laranjeira

CIK 1524338 · View on SEC EDGAR ↗

Insider

First SEC filing: June 15, 2018 · Latest: June 15, 2018

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 24 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

24 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 8, 2022 PCRX S 10b5-1 267 $61.98 $16,549 25,852 Direct -1.02% Disposed -61.3% (price as of 2026-08-21)
June 8, 2022 PCRX S 10b5-1 516 $60.99 $31,471 26,119 Direct -1.94% Disposed -60.7% (price as of 2026-08-21)
June 8, 2022 PCRX S 10b5-1 1,633 $60.23 $98,356 26,635 Direct -5.78% Disposed -60.2% (price as of 2026-08-21)
June 8, 2022 PCRX S 10b5-1 2,521 $59.08 $148,941 28,268 Direct -8.19% Disposed -59.4% (price as of 2026-08-21)
June 6, 2022 PCRX S 10b5-1 2,813 $61.37 $172,634 30,789 Direct -8.37% Disposed -60.9% (price as of 2026-08-21)
June 4, 2021 PCRX S 2,117 $61.04 $129,222 18,681 Direct -10.18% Disposed -60.7% (price as of 2026-08-21)
Aug. 3, 2020 PCRX S 10b5-1 2,500 $52.68 $131,700 20,796 Direct -10.73% Disposed -54.5% (price as of 2026-08-21)
June 29, 2020 PCRX S 10b5-1 1,778 $52.03 $92,509 20,250 Direct -8.07% Disposed -53.9% (price as of 2026-08-21)
June 29, 2020 PCRX S 10b5-1 6,859 $51.77 $355,090 22,028 Direct -23.74% Disposed -53.7% (price as of 2026-08-21)
June 29, 2020 PCRX S 10b5-1 51,464 $50.01 $2,573,715 28,887 Direct -64.05% Disposed -52.0% (price as of 2026-08-21)
June 4, 2020 PCRX S 863 $46.33 $39,983 10,101 Direct -7.87% Disposed -48.2% (price as of 2026-08-21)
June 4, 2019 PCRX S 430 $42.91 $18,451 5,367 Direct -7.42% Disposed -44.1% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 14, 2022 PCRX Stock Option (Right to Buy) Common Stock (6,000) $38.35 June 13, 2028 6,000 Disposed
June 8, 2022 PCRX Stock Option (Right to Buy) Common Stock (24,800) $59.39 June 8, 2032 24,800 Acquired
Nov. 22, 2021 PCRX Stock Option (Right to Buy) Common Stock (7,500) $44.10 June 2, 2027 7,500 Disposed
June 9, 2021 PCRX Stock Option (Right to Buy) Common Stock (17,500) $60.96 June 9, 2031 17,500 Acquired
Aug. 3, 2020 PCRX Common Stock Common Stock (2,500) $44.10 June 2, 2027 2,500 Disposed
June 29, 2020 PCRX Stock Option (Right to Buy) Common Stock (30,000) $44.10 June 2, 2027 30,000 Disposed
June 29, 2020 PCRX Stock Option (Right to Buy) Common Stock (7,500) $43.54 June 5, 2029 7,500 Disposed
June 29, 2020 PCRX Stock Option (Right to Buy) Common Stock (15,000) $38.35 June 13, 2028 15,000 Disposed
June 29, 2020 PCRX Stock Option (Right to Buy) Common Stock (3,750) $37.81 Jan. 3, 2029 3,750 Disposed
June 9, 2020 PCRX Stock Option (Right to Buy) Common Stock (35,000) $47.65 June 9, 2030 35,000 Acquired
June 5, 2019 PCRX Stock Option (Right to Buy) Common Stock (30,000) $43.54 June 5, 2029 30,000 Acquired
June 13, 2018 PCRX Stock Option (Right to Buy) Common Stock (30,000) $38.35 June 13, 2028 30,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
June 15, 2018 PCRX Common Stock 238 Direct
June 15, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (40,000) 40,000 Direct